Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools

Abstract Circulating cell-free DNA (cfDNA) has the potential to be a specific biomarker for the therapeutic management of lung cancer patients. Here, a new sequencing error-reduction method based on molecular amplification pools (MAPs) was utilized to analyze cfDNA in lung cancer patients. We determ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jessica Garcia, Nick Kamps-Hughes, Florence Geiguer, Sébastien Couraud, Brice Sarver, Léa Payen, Cristian Ionescu-Zanetti
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/da8aee7bdc1c403a8d63c53a6d8142ba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!